LIXTE BIOTECHNOLOGY HLDGS IN's ticker is LIXT and the CUSIP is 539319202. A total of 16 filers reported holding LIXTE BIOTECHNOLOGY HLDGS IN in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $27,090 | -34.4% | 32,745 | -59.6% | 0.00% | – |
Q4 2022 | $41,297 | -8.2% | 81,133 | 0.0% | 0.00% | – |
Q3 2022 | $45,000 | -27.4% | 81,133 | -3.4% | 0.00% | – |
Q2 2022 | $62,000 | -39.8% | 83,958 | 0.0% | 0.00% | – |
Q1 2022 | $103,000 | +12.0% | 83,958 | +8.7% | 0.00% | – |
Q4 2021 | $92,000 | -43.2% | 77,208 | -1.0% | 0.00% | – |
Q3 2021 | $162,000 | -28.0% | 77,955 | +4.8% | 0.00% | – |
Q2 2021 | $225,000 | – | 74,383 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SANTA MONICA PARTNERS LP | 166,667 | $548,000 | 0.35% |
Almanack Investment Partners, LLC. | 1,042,105 | $3,429,000 | 0.35% |
SABBY MANAGEMENT, LLC | 79,735 | $262,000 | 0.05% |
WELLS FARGO & COMPANY/MN | 16 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
Tower Research Capital LLC (TRC) | 1,574 | $5,000 | 0.00% |
MORGAN STANLEY | 21,053 | $69,000 | 0.00% |
BlackRock Inc. | 303 | $1,000 | 0.00% |
Citadel Advisors | 23,813 | $79,000 | 0.00% |